Brief: Oncopeptides Q2 Operating Profit SEK -56.234 Million
21/08/2025 07:00
Aug 21 (Reuters) - Oncopeptides AB ONCO.ST: Q2 ADJUSTED FREE CASH FLOW SEK -54.411 MILLION Q2 NET INCOME SEK -62.849 MILLION Q2 OPERATING PROFIT SEK -56.234 MILLION Q2 ADJUSTED EPS SEK -0.3 Q2 NET SALES SEK 19,183 MILLION Source text: ID:nMFN6smqmh Further company coverage: ONCO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy